about time the cost of trials is ridiculous the timelines are ridiculous finally someone is starting to understand the magnitude of the problem in suffering and cost
this should hasten pbt mkt launch petiiculary if HDT trial is good orphan status will get pbt on mkt quicker and possible back door for alzheimers if FDA allows q1uicker trials
fda proposes to lower the bar on alzheimer's d, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $200 | 66.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 74908609 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 5286356 | 4 |
View Market Depth
| Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |